Evidence map›Paper›PMID 39710618›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Self-Reported Cervical Cancer Screening Uptake Among Women of Reproductive Age in Zambia: Evidence from the 2021 Zambia Population-Based HIV Impact Assessment (ZAMPHIA) Survey.

Mwansa Ketty Lubeya, Angela Sinyani, Moses Mukosha, Brianna Lindsay, Enock Mulowa Mumbula, Chinedu Agbakwuru, Bwalya Daka, Rebecca G Nowak, Akipu Ehoche, Gina Mulundu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mwansa Ketty LubeyaDepartment of Obstetrics and Gynaecology, School of Medicine, University of Zambia, Lusaka, Zambia.ORCID 0000-0002-8526-3410
Angela SinyaniDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Moses MukoshaYoung Emerging Scientists Zambia, Lusaka, Zambia.
Brianna LindsayCenter for International Health Education and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Enock Mulowa MumbulaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Chinedu AgbakwuruCenter for International Health Education and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Bwalya DakaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Rebecca G NowakCenter for International Health Education and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Akipu EhocheCenter for International Health Education and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Gina MulunduDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite Zambia implementing the World Health Organisation's (WHO) tri-pillar cervical cancer prevention goals 90-70-90 Prevent, Screen, and Treat, cervical cancer claims 2000 lives annually and reigns as the most common cancer among women, especially those living with HIV (WLHIV). Our study describes the national uptake of screening and treatment from the ZAMPHIA 2021 survey.

methodsUtilising a two-stage cluster sampling approach, the study included participants aged 15 years and older across Zambia's ten provinces. Data were collected on demographic traits, reproductive history, sexual behaviour, and cervical cancer prevention using a structured questionnaire, and HIV was diagnosed from biological samples. Women aged 15-49 were eligible for inclusion in the analysis. The primary outcome of interest was whether a woman self-reported being screened for cervical cancer. Sociodemographic characteristics were calculated for categorical variables using the SAS proc surveyfreq procedure, producing both raw and weighted estimates. The weighted estimates and their variance were generated using jackknife replicate weights for each record.

resultsOf the 8801 surveyed women, 22.2% reported undergoing cervical cancer screening, the majority being aged between 35-49 years. Cervical cancer screening uptake was more likely among compared to HIV negative counterparts (aOR = 3.92, 95% CI: 3.10, 4.95), those aged 25-34 years (aOR = 1.76, 95% CI: 1.42, 2.21) or 35-49 years (aOR = 2.65, 95% CI: 2.11, 3.33) than younger and those with 1-4 (aOR = 2.16, 95% CI: 1.54, 3.02) or more than 5 live births (aOR = 1.98, 95% CI: 1.37, 2.87) than none. Marital status, WLHIV, education, and parity were other factors significantly associated with screening.

conclusionWe report low cervical cancer screening uptake compared to the 70% target of WHO. The WHO's call for bolstered strategies and efforts to increase cervical cancer screening and treatment is timely and urgent. Therefore, ongoing messaging and health education among all women is key.

Indexed as

Early Detection of CancerHIV InfectionsUterine Cervical NeoplasmsAdolescentAdultFemaleHumansMass ScreeningMiddle AgedSelf ReportSurveys and QuestionnairesYoung AdultZambiacervical cancercervical cancer screeningHIVHPVHPV vaccinationmultiparityZambiaZAMPHIA

Identifiers

PMID39710618
PMCPMC11664511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.